Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

• Publication date

  2014-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/21678421.2013.839708PMID 24102512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humans

  2012cited by this paper
• Proposed criteria for familial amyotrophic lateral sclerosis

  2011cited by this paper
• Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

  2011cited by this paper
• Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals

  2010cited by this paper
• Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease

  2010cited by this paper
• Genetic Analysis of Cytoprotective Functions Supported by Graded Expression of Keap1

  2010cited by this paper
• Functional Haplotypes in the Promoter Region of Transcription Factor Nrf2 in Chronic Obstructive Pulmonary Disease

  2010cited by this paper
• Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population

  2009cited by this paper
• Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase.

  2009cited by this paper
• The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity.

  2008cited by this paper
• Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis

  2008cited by this paper
• Nuclear Erythroid 2-Related Factor 2-Antioxidative Response Element Signaling Pathway in Motor Cortex and Spinal Cord in Amyotrophic Lateral Sclerosis

  2008cited by this paper
• Nrf2 gene promoter polymorphism is associated with ulcerative colitis in a Japanese population.

  2008cited by this paper
• The susceptibility to vitiligo is associated with NF‐E2‐related factor2 (Nrf2) gene polymorphisms: a study on Chinese Han population

  2008cited by this paper
• Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons

  2007cited by this paper
• Mitochondrial Superoxide Production and Nuclear Factor Erythroid 2-Related Factor 2 Activation in p75 Neurotrophin Receptor-Induced Motor Neuron Apoptosis

  2007cited by this paper
• The relationship between Helicobacter pylori infection and promoter polymorphism of the Nrf2 gene in chronic gastritis.

  2007cited by this paper
• Genetic variations and haplotype structures of transcriptional factor Nrf2 and its cytosolic reservoir protein Keap1 in Japanese.

  2007cited by this paper
• Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury

  2007cited by this paper
• Oxidative and Electrophilic Stresses Activate Nrf2 through Inhibition of Ubiquitination Activity of Keap1

  2006cited by this paper
• Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene

  2006cited by this paper
• Nervous system disorders

  2006cited by this paper
• EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives

  2005cited by this paper
• [International HapMap project].

  2005cited by this paper
• Haploview: analysis and visualization of LD and haplotype maps

  2005cited by this paper
• BTB Protein Keap1 Targets Antioxidant Transcription Factor Nrf2 for Ubiquitination by the Cullin 3-Roc1 Ligase

  2005cited by this paper
• Fibroblast Growth Factor-1 Induces Heme Oxygenase-1 via Nuclear Factor Erythroid 2-related Factor 2 (Nrf2) in Spinal Cord Astrocytes CONSEQUENCES FOR MOTOR NEURON SURVIVAL*

  2005cited by this paper
• Fibroblast Growth Factor-1 Induces Heme Oxygenase-1 via Nuclear Factor Erythroid 2-related Factor 2 (Nrf2) in Spinal Cord Astrocytes

  2005cited by this paper
• Heme oxygenase expression in human central nervous system disorders.

  2004cited by this paper
• Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra.

  2004cited by this paper
• The Keap1-BTB Protein Is an Adaptor That Bridges Nrf2 to a Cul3-Based E3 Ligase: Oxidative Stress Sensing by a Cul3-Keap1 Ligase

  2004cited by this paper
• Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation

  2003cited by this paper
• The International HapMap Project

  2003cited by this paper
• The Structure of Haplotype Blocks in the Human Genome

  2002cited by this paper
• Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain.

  1999cited by this paper
• Nrf2, a Cap’n’Collar Transcription Factor, Regulates Induction of the Heme Oxygenase-1 Gene*

  1999cited by this paper
• An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements.

  1997cited by this paper
• Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene.

  1996cited by this paper
• Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population.

  1995cited by this paper

• Nrf2-Activating Natural Compounds in Neurodegenerative Diseases: Targeting Oxidative Stress and Protein Aggregation

  2026cites this paper
• Health position paper and redox perspectives – Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases

  2025cites this paper
• Microglial Nrf2 Functions as a Cell‐Autonomous Regulator of Neuroinflammation and Trained Immunity in the Aging Brain

  2025cites this paper
• M102 activates both NRF2 and HSF1 transcription factor pathways and is neuroprotective in cell and animal models of amyotrophic lateral sclerosis

  2025cites this paper
• PKM2 Alleviates Mitochondrial Oxidative Stress and Neuronal Apoptosis through Metabolic and Non-metabolic Pathways to Protect SOD1G93A Mice.

  2025cites this paper
• Current neuroprotective therapies and future prospects for motor neuron disease.

  2024cites this paper
• Upregulated miR-10b-5p as a potential miRNA signature in amyotrophic lateral sclerosis patients

  2024cites this paper
• The SIRT-1/Nrf2/HO-1 Axis: Guardians of Neuronal Health in Neurological Disorders.

  2024cites this paper
• Sulforaphane acts through the NFE2L2/AMPK signaling pathway to protect boar spermatozoa from cryoinjury by activating antioxidant defenses.

  2024cites this paper
• Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases

  2024cites this paper
• Proteomic investigation of ALS motor cortex identifies known and novel pathogenetic mechanisms.

  2023cites this paper
• Bilirubin and Redox Stress in Age-Related Brain Diseases

  2023cites this paper
• Association of NEF2L2 Rs35652124 Polymorphism with Nrf2 Induction and Genotoxic Stress Biomarkers in Autism

  2023cites this paper
• New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

  2022cites this paper
• Resveratrol, Endocrine Disrupting Chemicals, Neurodegenerative Diseases and Depression: Genes, Transcription Factors, microRNAs, and Sponges Involved

  2022cites this paper
• Role of Nrf2 in Aging, Alzheimer's and Other Neurodegenerative Diseases.

  2022cites this paper
• Integrative Analysis of Motor Neuron and Microglial Transcriptomes from SOD1G93A Mice Models Uncover Potential Drug Treatments for ALS

  2022cites this paper
• Genetic variation in NFE2L2 is associated with outcome following aneurysmal subarachnoid haemorrhage

  2022cites this paper
• Research for type 2 diabetes mellitus in endemic arsenism areas in central China: role of low level of arsenic exposure and KEAP1 rs11545829 polymorphism

  2022cites this paper
• NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS.

  2021cites this paper
• Nrf2/Keap1/ARE signaling: Towards specific regulation

  2021influential citation
• The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention

  2021cites this paper
• Rare and common genetic variations in the Keap1/Nrf2 antioxidant response pathway impact thyroglobulin gene expression and circulating levels, respectively.

  2020cites this paper
• Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

  2019cites this paper
• Targeting the cell signaling pathway Keap1-Nrf2 as a therapeutic strategy for adenocarcinomas of the lung

  2019cites this paper
• Astrocytes in Motor Neuron Diseases.

  2019cites this paper
• Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy

  2018cites this paper
• Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach

  2018cites this paper
• Association of single-nucleotide polymorphisms of the KEAP1 gene with the risk of various human diseases and its functional impact using in silico analysis.

  2018cites this paper
• Aberrant regulation of the GSK‐3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy

  2018cites this paper
• Nrf2 and rip140 as new therapeutic targets for x-linked adrenoleukodystrophy (x-ald): control of redox/metabolic homeostasis and inflammation

  2017influential citation
• Genetic Variations and mRNA Expression of NRF2 in Parkinson's Disease

  2017cites this paper
• Association of polymorphisms in NFE2L2 gene encoding transcription factor Nrf2 with multifactorial diseases

  2017cites this paper
• ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling

  2016cites this paper
• NRF2 in neurodegenerative diseases

  2016cites this paper
• Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes

  2016cites this paper
• ALSUntangled No. 31: Protandim

  2016cites this paper
• RBM45 Modulates the Antioxidant Response in Amyotrophic Lateral Sclerosis through Interactions with KEAP1

  2015cites this paper
• Association of KEAP1 and NFE2L2 polymorphisms with temporal lobe epilepsy and drug resistant epilepsy.

  2015influential citation
• Nrf2, a master regulator of detoxification and also antioxidant, anti-inflammatory and other cytoprotective mechanisms, is raised by health promoting factors.

  2015cites this paper
• Functional polymorphisms in Nrf2: implications for human disease.

  2015cites this paper
• AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION

  2015cites this paper
• Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.

  2015cites this paper
• 1 Nrf 2 regulator of detoxification , antioxidant , antiinflammatory and cytoprotection is raised by health promoting factors

  2014cites this paper